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Abstract: This study was conducted to investigate the effects of Epimedium polysaccharide (EPS) on ovarian and uterine development in
female mice and assess the in vitro maturation (IVM) rate. Healthy Kunming female mice were divided into 4 groups and administered
2, 4, 6, and 8 mg/0.1 mL of EPS, respectively; the control group was given 0.1 mL of 0.9% physiological saline solution. After 7 and 14
days, the mice were sacrificed and their reproductive tracts (uterus, oviduct, and ovaries) were removed. The reproductive tract was
weighed; some ovaries were punctured to harvest oocytes for IVM culture and the others were used for histological analysis. EPS had
virtually no effect on the body weight of the female mice. EPS at 4 mg/0.1 mL for 14 days of treatment had a significant effect (P < 0.05)
on ovarian and uterine development when compared with 2, 6, and 8 mg/mL but no significant effect (P > 0.05) when compared with
the control group. The number of follicles increased in the experimental groups and the arrangements of ovarian follicles were not
negatively affected during histological observation. In conclusion, EPS at appreciable dosages has a positive effect on mouse ovarian
development.
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1. Introduction
The genus Epimedium has been used as a tonic drug
in traditional Chinese medicine for centuries and is
officially listed in the Chinese Pharmacopoeia. There are
more than 60 species of this herbaceous flowering plant
belonging to the family Berberidaceae (1,2). It has several
common names, such as horny goat weed, bishop’s hat,
fairy wings, rowdy lamb herb, and barrenwort, due to its
wide usage. In addition, the various species of the plant
genus Epimedium have been used in the treatment of a
variety of human illnesses. Colloquially known as “yin
yang huo” in Chinese, these plants have, as their names
imply, been of particular interest for their perceived
efficacy in the management of sexual concerns (3). Many
of these Chinese herbs and their constituents have been
reported to have the effect of immune enhancement (4,5)
and they have great potential in practical applications
in China, Korea, and Japan. For instance, many studies
have demonstrated that Epimedium plants have extensive
pharmacological efficacy for treating infertility, impotence,
spermatorrhea, amenorrhea, rheumatic arthritis, chronic
bronchitis (6,7), and the genus has been proven to have
estrogen-like and antiosteoporotic activity and is used
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for the treatment of osteoporosis, menopausal syndrome,
and age-associated diseases (8). These traditional Chinese
medicines containing multiple interactive compounds
have attracted the attention of researchers for their effects
in the management of menopausal and related medical
conditions (9). The polyphenolic extract of the leaves of
Epimedium brevicornum was also reported to exhibit
significant estrogenic activity in a recombinant yeast cell
assay and the Ishikawa Var-I assay (10). In another in vivo
study, the ethanolic E. brevicornum extracts increased
estrogen receptor α activity in rats after oral administration
(11).
Research has shown that ovarian follicular growth and
development begins when primordial follicles emerge from
their quiescent state. The initiation of follicular growth
is characterized by morphologic changes, including a
change in granulosa cell shape from flattened to cuboidal,
proliferation of granulosa cells, enlargement of the
oocyte, and formation of the zona pellucida. Granulosa
cell proliferation and the change to a cuboidal shape
precede increases in oocyte diameter. In humans, the first
substantial increase in oocyte diameter occurs when there
are 15 granulosa cells in the largest follicle cross-section
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(12). In the present study, we set out to examine how
Epimedium polysaccharide EPS affects the growth and
development of mouse ovarian follicles and uterus.
2. Materials and Methods
2.1. Animals
Healthy Kunming female mice weighing approximately 23
g (4 weeks old) were purchased from Shanghai Laboratory
Animal Center, Chinese Academy of Sciences (Permit No.
SCXK - Hu 2012 - 0002) and used in this experimental
study. All mice were routinely raised in a clean area with
normal room temperature and fed with standard mouse
feed and ordinary water ad libitum. The treated groups
received EPS at 2, 4, 6, and 8 mg/0.1 mL for 7 or 14 days. The
control group was orally administered 0.9% physiological
saline (sodium chloride) solution. All procedures and
protocols involving animals were approved by the Animal
Research Committee of Nanjing Agricultural University
(NJAU) with reference to the Guide for the Care and Use
of Laboratory Animals (13).
2.2. Experimental design
The type of study employed in this experiment was a
randomized controlled clinical trial. Sixty Kunming female
mice were randomly divided into 10 groups (n = 6) and
treatment started 1 week after acclimatization to the new
environment. The EPS was kindly provided by Dr Deyun
Wang of the Laboratory of Traditional Chinese Medicine
of NJAU and dissolved as well as diluted with ordinary
water to prepare the medicine for the experiment. The mice
were orally administered EPS (for the treatment group)
and 0.9% saline solution (for the control group) through
a cannula fitted to a 1.0-mL syringe and euthanasia was
performed 7 or 14 days after treatment.
The mice were weighed before treatment and at the time
of sacrifice to determine the difference in weight from the
time of treatment to sacrifice. After the 7 or 14 days of EPS
treatment, the mice were humanely sacrificed by cervical
dislocation and the female reproductive system (uterus,
oviduct, and ovaries) was removed after the abdomen was
opened by a small lateral incision at the midline.
2.3. Preparation of fixatives and tissue culture media
Bouin’s solution (for ovary fixation) and tissue culture
medium M16 (for oocyte maturation) and human tubal
fertilization (HTF) medium (for in vitro fertilization) were
prepared before the mice were sacrificed. These media
were prepared according to the guidelines and protocols
from the textbook Manipulating the Mouse Embryo: A
Laboratory Manual (14).
2.3.1. Bouin’s solution
Bouin’s solution was prepared as follows: 75 mL of
saturated picric acid aqueous solution, 25 mL of 40%
formalin aqueous solution, and 5 mL of acetic acid.

2.3.2. M16 medium and HTF medium
The M16 medium and HTF medium were prepared
according to Behringer et al. (14).
2.4. Ovarian tissue preparation
Ovaries and uteri were carefully examined, removed from
the mice, and collected onto filter papers for weighing and
fixation in Bouin’s solution or tissue culture.
2.4.1. For weighing
Paired uterine horns and ovaries were weighed on an
analytical electronic balance. They were then distributed
into Bouin’s solution bottles and petri dishes containing
PBS for various experiments.
2.4.2. For Bouin’s fixation
The ovaries from each group of mice were placed in
Bouin’s solution for 24 h to preserve normal morphology
and facilitate further processing into paraffin blocks.
2.5. Oocyte culture in vitro
On the day of sacrifice, ovaries from each group [control
(0 mg/0.1 mL) and 2 mg/0.1 mL, 4 mg/0.1 mL, 6 mg/0.1
mL, and 8 mg/0.1 mL of EPS for 7 or 14 days] were
punctured in separate petri dishes containing PBS under
a microscope to collect oocytes. The oocytes were then
aspirated with a mouth-controlled pipette into petri dishes
containing PBS for washing. Next, 5 microdrops of M16
were added to different tissue culture dishes representing
the groups and covered with mineral oil. The media
microdrops were prepared and equilibrated at 37 °C in
a CO2 incubator overnight. The oocytes were carefully
dropped in each microdrop and cultured in the incubator
for 20–24 h. After in vitro maturation, oocytes were
checked for the extrusion of their first polar bodies (pbI)
under a stereomicroscope (SMZ140, Nikon). With the
maturated oocytes, in vitro fertilization was conducted.
Semen were obtained from the epididymis of healthy male
mice of the same strain and capacitated in HTF medium
for 90 min at 37 °C in a CO2 incubator. Fertilization results
were read after 6 h as pronuclei formation.
2.6. Determination of reproductive index
The reproductive index (RI) was determined using the
recorded weight values, live weight of mice before sacrifice
and weight of reproductive tract (the uterus, oviduct, and
ovaries). The RI was calculated from the ratio of the weight
of the female reproductive tract to the live weight of the
mice and expressed as a percentage:
RI = [FRT weight (g) / live weight (g)] × 100,
where FRT = female reproductive tract, FRT weight =
weight (ovary + uterus + oviduct), and live weight = weight
of the mouse before it was sacrificed.
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2.7. Preparation of histological sections of mice ovaries
Isolated mice ovaries were fixed in Bouin’s fixative for
24 h, washed in PBS, and dehydrated through a graded
series of ethanol baths (70% for 1 h, 80% for 1 h, and
90% 2 h, to 100% for 3 h). The sections were cleared in
a dimethylbenzene and ethanol mixture (1:1, v/v) for 60
min and then put into dimethylbenzene until transparent
and embedded in a dimethylbenzene and paraffin mixture
(1:1, v/v) for 1 h, followed by paraffin for 2 h. Sections (5
mm) were deparaffinized in dimethylbenzene, rehydrated
through a graded series of ethanol solutions (from 100% to
70%), and finally stained with H&E.
2.8. Statistical analysis
Data were collated and analyzed as mean and standard
deviation (SD). Statistical analysis was performed using
SPSS 20.0 (IBM Corporation, Armonk, NY, USA). The
significant differences were determined using one-way
ANOVA. The level of significance was set at P < 0.05.
3. Results
3.1. Effects of EPS on body weight
Healthy female mice were exposed to different doses of
EPS, and body weight was measured after 7 or 14 days.
The body weight did not change significantly in any group
(P > 0.05), suggesting that EPS has no obvious effects on
female mouse growth, which is in line with other similar
reports (15,16).
3.2. Effects of EPS on reproductive index
When the female mice were administered with different
doses of EPS continuously for 7 and 14 days, there were
no negative effects on the body weight of the mice. There
was a marginal increase in the body weight of the mice.
The RI value of the 4 mg/0.1 mL group for 14 days was
significantly higher than that of other treatment groups (2,
6, and 8 mg/0.1 mL), but not that of the control (Table 1).
3.3. Oocyte culture evaluation
Table 2 summarizes the pbI extrusion rates of the oocytes.
The percentage of oocytes that extruded pbI after culture

was higher in the treated groups as compared to the control.
However, there were no differences between experimental
groups (except the 8 mg/0.1 mL group for 7 days) and the
control (P > 0.05). The 8 mg/0.1 mL group had the highest
pbI rates at 7 days and the 4 mg/0.1 mL group had the
highest pbI rate at 14 days.
3.4. Histological evaluation
EPS was given orally to adult female mice for 7 and 14
days and then animals were sacrificed respectively. No
histopathological alterations in the ovaries were observed
in the control or EPS-treated mice. Ovarian follicles
appeared normal morphologically and the theca cells and
basal laminas of developing follicles were continuous and
complete. There seemed to be no significant differences
for the number and size of antral follicles among groups.
Morphological findings suggested that the EPS did not
adversely affect ovarian histology. Other histological
observations include the following: in the experimental
groups, ovarian follicles were developing normally, as in
the control groups, with primordial follicles being the least
developed. A careful observation under the microscope
revealed that the EPS experimental groups had higher
numbers of primordial, primary, and secondary follicles,
but none of the follicles had reached the Graafian follicle
stage of development. The control group had more
primordial and primary follicles. However, there were
many more secondary follicles in the experimental group
(2, 4, 6, and 8 mg/0.1 mL) than the control group, an
indication that EPS enhances follicular development.
4. Discussion
This study was designed to investigate the effects of EPS on
mouse ovarian and uterine development. The evaluation
of the treatments was done with RI, IVM, and histologic
analyses, in addition to weight measurements.
EPS, an active ingredient of Epimedium, has been
reported to possess mitogenic-like function and promote
the incorporation of 3H-TdR in mice thymocytes (17).
However, little is known about its effect on mouse ovarian

Table 1. Reproductive indexes among groups.
Group (EPS dosage)

EPS, 7 days

EPS, 14 days

Control (0 mg/0.1 mL)

0.460 ± 0.041

1.088 ± 0.001

2 mg/0.1 mL

0.755 ± 0.004

0.906 ± 0.004

4 mg/0.1 mL

0.728 ± 0.007

1.419 ± 0.007*

6 mg/0.1 mL

0.623 ± 0.004

0.890 ± 0.004

8 mg/0.1 mL

0.475 ± 0.001

0.708 ± 0.002

*: P < 0.05.
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Table 2. Effects of EPS for 7 days and 14 days on IVM of mice oocytes.
EPS, 7 days

EPS, 14 days

EPS dosage

No. of oocytes
cultured

pbI extrusion
(%)

No. of oocytes
cultured

pbI extrusion
(%)

Control (0 mg/0.1 mL)

20

45.0

47

42.5

2 mg/0.1 mL

18

63.6

62

46.8

4 mg/0.1 mL

19

62.0

44

60.6

6 mg/0.1 mL

14

64.3

51

51.3

8 mg/0.1 mL

15

80.0*

48

41.7

*: P < 0.05.

and uterine development. As an experimental tool, we
showed that EPS had some significant effect on mouse
ovarian and uterine growth and development.
The RI calculations and statistical analysis showed
that values in the 4 mg/0.1 mL group at 14 days were
significantly higher than in other treatment groups (2, 6, 8
mg/0.1 mL), but not higher than those of the control.
The IVM experiments also showed that there were no
differences between experimental groups (except 8 mg/0.1
mL for 7 days) and the control (P < 0.05), and that the
8 mg/0.1 mL group had the highest pbI rates at 7 days
and the 4 mg/0.1 mL group had the highest pbI rate at 14
days. However, histologic analyses revealed that ovarian
follicles in the treatment groups developed normally
when compared with the control. The investigators also
concede that EPS may not be entirely responsible for the
development of the ovaries as strong evidence exists that
genes expressed in oocytes play a role in their growth and
development (18–21). Histologic observations showed
normal secondary follicle development with the formation
of the antrum, multiple granulosa cells (leading to the
formation of the membrane granulosa, cumulus oophorus,
and corona radiata), and oocyte nucleus. Ovarian
follicular developments were also seen in primary follicles
as these follicles were at various stages of development.
There were more follicles in the treatment groups than
the control groups. Faddy et al. reported that more than
half of the primordial follicles present in the mouse ovary
at birth degenerate before 3–5 weeks of age, but little is
known about the hormonal and local factors controlling
this loss (22). Eppig et al. also reported that the female
mouse reaches maturity at approximately 6 weeks of age,
depending on the strain and environmental conditions. By

this time, each ovary contains approximately 104 oocytes
at different stages of maturity. Techniques have been
established for isolating and culturing both immature
oocytes from preantral follicles and mature oocytes from
antral follicles (23,24). Maturation of oocytes from antral
follicles occurs spontaneously under these conditions; they
can be fertilized in vitro and develop normally thereafter.
Oocytes from preantral follicles, on the other hand, must
be cultured for several days with their surrounding follicle
cells before they can be fertilized in vitro.
The findings suggest that EPS has an effect on mouse
ovarian and uterine development and could be useful for
reproductive medicine. We think that at the end of the
comprehensive research on EPS we will be able to tell
how EPS actually works on the ovaries and uteri of mice
to enhance their development. This research revealed that
EPS as a constituent of herbal Epimedium enhances female
reproductive system development when administered
at appreciable doses to matured female mice; however,
its effect on reproductive system development may not
be seen if the dosage is very low. The effect may also be
harmful if the dosage is very high. This is the first report
in this regard, and further research is being conducted to
determine how EPS actually works, because the results of
our preliminary study did not show how EPS works on the
reproductive system development of female mice.
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